ATAI

$7.25+$0.02 (+0.28%)live

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Market cap

$2.7B

371M shares

52-week range

$3.27 – $7.26

100% from low

Sector

PHARMACEUTICAL PREPARATIONS

Exchange

NASDAQ

Change$-7.50

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$1M	-54.9%	$-0.42	$-0.70–$-0.30	—	10
2027	$650000	-52.0%	$-0.43	$-0.55–$-0.24	—	8
2028	$812500	+25.0%	$-0.43	$-0.63–$-0.18	—	12
2029	$79M	+9662.5%	$-0.34	$-0.35–$-0.34	—	9

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-11	$-0.11	$-0.09	+15.6%
2026-05-12	$-0.11	$-0.08	+27.3%
2026-03-06	$-0.12	$-0.05	+58.3%
2025-11-12	$-0.12	$-0.28	-133.3%
2025-08-14	$-0.12	$-0.14	-16.7%
2025-05-14	$-0.19	$-0.15	+21.1%
2025-03-17	$-0.14	$-0.24	-71.4%
2024-11-13	$-0.15

DCF fair valuemodel estimate

Intrinsic value

$0.19

Price

$7.25

Implied downside

-97%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ATAIAtai Beckley Inc.	$7.25	+0.28%	$2.7B	—
AMLXAmylyx Pharmaceuticals, Inc.	$22.48	-3.73%	$2.5B	—
DNTHDianthus Therapeutics, Inc.	$109.60	-2.50%	$6.1B	—
ELVNEnliven Therapeutics, Inc.	$58.06	+0.24%	$4.1B	—
IMTXImmatics N.V.	$9.59	-1.24%

AtaiBeckley Inc. Common Stock

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

www.ataibeckley.com

Employees: 99
IPO / List date: Jun 18, 2021
HQ: NEW YORK, NY

Held by traders on TradeandTell

No one on the platform currently holds ATAI.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ATAI as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ATAI yet.

$ATAI chatter on StockTwits

Shanise Sanford@BougieRBullish6h
$ATAI is this going higher before End of month?
View on StockTwits ↗
Taxidriver@taxidriver514Bullish6h
$JUNS @ChartGuysDan Is this the next Psychedelic runner ? $CMPS $DFTX $ATAI
View on StockTwits ↗
San Juan@Rocketzz1d
@laidbacklu @DeepValueStocks I understand owning all these stocks in the long run. I believe there will be room for 3 players in the end. But $DFTX is years ahead $ATAI
View on StockTwits ↗
Frank Ben@sonofyama1d
Watching $DFTX $CMPS and $HELP making strong gains over the past month really makes me wonder where $ATAI would've been if they hadn't sold out so cheap.
View on StockTwits ↗
Millionaire11@Millionaire11Bullish1d
$CMPS $DFTX $HELP $ATAI Question and answer at the Canaccord Genuity’s conference directed at $CMPS Question - So I'd be doing a disservice to your efforts if I didn't mention that you also have a program in PTSD. How excited are you about that? And then this is a bigger picture question, which we can end with. You know, there's lots of the markets are large here, right? We appreciate that. We also appreciate that patients respond differently to different products. So given those variables, what do you think your key differentiator could be for comp 360 versus other psychedelic therapeutics that may also be approved and be on the market? Start PTSD. Sure. Yeah. How excited are we about PTSD? Answer - Like jumping up and down, excited. Yes. This, this is a huge unmet need. You know, we talk about the 4 million patients living with TRD who are underserved PTSD. There are 13 million adults in the US with PTSD. Continued below.
View on StockTwits ↗
Thomas Prindle@brunoq141d
$ATAI At this price I may just sell.
View on StockTwits ↗
CoffeeRocks@CoffeeRocksBullish2d
$ACB $ATAI Atai Went over 9$ until bid came in at 7$ See the same here 4.5$s with a 4$ bid
View on StockTwits ↗
CoffeeRocks@CoffeeRocksBullish2d
$EBS $ABCL $ATAI $BTAI $AEMD Bio week kicking off
View on StockTwits ↗
CoffeeRocks@CoffeeRocksBullish2d
@Bruno_C 4$ on the table plus CVR ACB will sell 100% $ATAI Until offer tendered could be multiple parties interested
View on StockTwits ↗
CoffeeRocks@CoffeeRocksBullish2d
$ACB $ATAI $ABCL $SLS The real volume starts AH and premarket Approval will send this higher 4-5$s
View on StockTwits ↗
Jim Tomiser@UncleJudd2d
@leLu83 But wait .... weren't you completely wrong about $ATAI and you lost your shirt? 😂
View on StockTwits ↗
KeepLossesSmall@KeepLossesSmall2d
$HELP Been holding this for years and it has admittedly always been a pos but I feel like this time it’s different. Something’s changed. $ATAI being bought out legitimized the sector and this is the most sustained multiday run I’ve seen in this stock in a while. Volume is at the highest in the most recent months. I think this is just a pullback and the run has more legs. This has a 620k market cap while the other big names are 3-6 billion market cap. I think some big players or degenerates see the value and will keep bidding up until we hit 1B market cap at least. Bought 1k more shares at $10 and holding for now. Hope we don’t get fucked by an offering.
View on StockTwits ↗
George Jetson@GeorgeJetson173d
$ATAI The shareholder vote on the Lilly merger is now scheduled for Sept 8th - so if there’s going to be any chance of another company offering more, needs to happen soon (I think it’s highly unlikely). https://www.sec.gov/Archives/edgar/data/2081043/000114036126031922/ny20078129x2_defm14a.htm
View on StockTwits ↗
CoffeeRocks@CoffeeRocksBullish3d
$BTAI $PGEN $ABCL $ATAI $AEMD Bio week kicking off
View on StockTwits ↗
KeepLossesSmall@KeepLossesSmall6d
$ATAI Hypothetically, if another entity is going to step in and pay higher for the buy out, insiders who know would bid the stock up. Right now I’m planning to sell if it somehow hits $8, yet if it hits $8, it’s a sign that something is brewing… someone may buy it for much higher than 8 and it makes sense for them to bid it up so everyone else will sell it at $8 thinking it’s a great price and then it’ll fly to $11 Just dreaming
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.